Presentation of the Université libre de Bruxelles
version françaiseversion françaisecontentcontentprevious pageprevious pageprintprintsendsendmarkmark

The Université libre de Bruxelles, actor of economic development and regional grounding

ULB is actively involved in the economic development of the regions it is located in. Often called upon, particularly by government, it carries out many public management study and support missions, notably in the fields of health, education, land use planning, TICs and socio-economy.

ULB is associated with the management of several industrial and science parks in Brussels and the Walloon region. They house three company centres: Solvay Entrepreneurs, the European Erasmus Business and Innovation Centre (EEBIC) in Brussels, and Wallonia Biotech in Charleroi (Gosselies). The Aeropole at Gosselies is also home to Immune Health, a collective research centre for molecular biology and biomedical sciences created in 2001 downstream of research projects carried out at ULB and UMons.

In the Brussels Region, where the University's headquarters are located, ULB plays a leading role in the TIC programme (Information and Communication Technologies), part of the region's innovation plan (PRI).

In the Walloon Region, the Biopark Charleroi Brussels South is a perfect illustration of a successful integrated project which brings together local and regional governments and industrial and university partners. With about 500 people, the Biopark was created around:

The Institute for Biology and Molecular Medicine (IBMM) created in 1999 with the help of European Structural Funds and the Walloon Region

The Institute for Medical Immunology (IMI), a partnership between the Glaxo Smithkline pharmaceutical group and ULB

Several spin-offs, an incubator and a processing centre for the results of academic research in new products and services

These value-adding technology transfer activities are fairly new to the University. They have expanded significantly over the past several years. ULB now has 22 spin-offs, which have created 275 jobs.